科研成果详情

题名The DDR-related gene signature with cell cycle checkpoint function predicts prognosis, immune activity, and chemoradiotherapy response in lung adenocarcinoma
作者
发表日期2022-07-15
发表期刊RESPIRATORY RESEARCH   影响因子和分区
语种英语
原始文献类型Article
关键词POLO-LIKE KINASES CANCER EXPRESSION ASSOCIATION METHYLATION
其他关键词POLO-LIKE KINASES ; CANCER ; EXPRESSION ; ASSOCIATION ; METHYLATION ; INHIBITION ; RESISTANCE ; APOPTOSIS ; TARGETS ; REPAIR
摘要Background: As a DNA surveillance mechanism, cell cycle checkpoint has recently been discovered to be closely associated with lung adenocarcinoma (LUAD) prognosis. It is also an essential link in the process of DNA damage repair (DDR) that confers resistance to radiotherapy. Whether genes that have both functions play a more crucial role in LUAD prognosis remains unclear. Methods: In this study, DDR-related genes with cell cycle checkpoint function (DCGs) were selected to investigate their effects on the prognosis of LUAD. The TCGA-LUAD cohort and two GEO external validation cohorts (GSE31210 and GSE42171) were performed to construct a prognosis model based on the least absolute shrinkage and selection operator (LASSO) regression. Patients were divided into high-risk and low-risk groups based on the model. Subsequently, the multivariate COX regression was used to construct a prognostic nomogram. The ssGSEA, CIBERSORT algorithm, TIMER tool, CMap database, and IC50 of chemotherapeutic agents were used to analyze immune activity and responsiveness to chemoradiotherapy. Results: 4 DCGs were selected as prognostic signatures, and patients in the high-risk group had a lower overall survival (OS).The lower infiltration levels of immune cells and the higher expression levels of immune checkpoints appeared in the high-risk group. The damage repair pathways were upregulated, and chemotherapeutic agent sensitivity was poor in the high-risk group. Conclusions: The 4-DCGs signature prognosis model we constructed could predict the survival rate, immune activity, and chemoradiotherapy responsiveness of LUAD patients.
资助项目Scientific Research Project of Wenzhou Medical University for Talent [QTJ20010]; National Natural Science Foundation of China [11635013]
出版者BMC
出版地LONDON
ISSN1465-993X
EISSN1465-993X
卷号23期号:1页码:190
DOI10.1186/s12931-022-02110-w
页数17
WOS类目Respiratory System
WOS研究方向Respiratory System
WOS记录号WOS:000826047400003
收录类别SCIE ; PUBMED ; SCOPUS
URL查看原文
发表状态已发表
PubMed ID35840978
SCOPUSEID2-s2.0-85134236334
通讯作者地址[Hu, Burong]Department of Radiation Medicine,School of Public Health and Management,Wenzhou Medical University,Wenzhou,325035,China
Scopus学科分类Pulmonary and Respiratory Medicine
引用统计
被引频次[WOS]:0   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/153370
专题公共卫生学院_放射卫生与放射医学系
公共卫生学院_预防医学系
通讯作者Hu, Burong
作者单位
1.Department of Radiation Medicine,School of Public Health and Management,Wenzhou Medical University,Wenzhou,325035,China;
2.Zhejiang Provincial Key Laboratory of Watershed Sciences and Health,Wenzhou Medical University,Wenzhou,325035,China;
3.South Zhejiang Institute of Radiation Medicine and Nuclear Technology,Wenzhou Medical University,Wenzhou,325035,China;
4.Department of Dermatology,Duke University Medical Center,Durham,27710,United States;
5.Department of Preventive Medicine,School of Public Health and Management,Wenzhou Medical University,Wenzhou,325035,China
第一作者单位公共卫生学院;  温州医科大学;  预防医学系
通讯作者单位公共卫生学院
第一作者的第一单位公共卫生学院
推荐引用方式
GB/T 7714
Li, Quan,Zhang, Pan,Hu, Huixiao,et al. The DDR-related gene signature with cell cycle checkpoint function predicts prognosis, immune activity, and chemoradiotherapy response in lung adenocarcinoma[J]. RESPIRATORY RESEARCH,2022,23(1):190.
APA Li, Quan., Zhang, Pan., Hu, Huixiao., Huang, Hang., Pan, Dong., ... & Hu, Burong. (2022). The DDR-related gene signature with cell cycle checkpoint function predicts prognosis, immune activity, and chemoradiotherapy response in lung adenocarcinoma. RESPIRATORY RESEARCH, 23(1), 190.
MLA Li, Quan,et al."The DDR-related gene signature with cell cycle checkpoint function predicts prognosis, immune activity, and chemoradiotherapy response in lung adenocarcinoma".RESPIRATORY RESEARCH 23.1(2022):190.

条目包含的文件

下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
李权-Respiratory Resea(4288KB)期刊论文作者接受稿开放获取CC BY-NC-SA浏览 下载
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Li, Quan]的文章
[Zhang, Pan]的文章
[Hu, Huixiao]的文章
百度学术
百度学术中相似的文章
[Li, Quan]的文章
[Zhang, Pan]的文章
[Hu, Huixiao]的文章
必应学术
必应学术中相似的文章
[Li, Quan]的文章
[Zhang, Pan]的文章
[Hu, Huixiao]的文章
相关权益政策
暂无数据
收藏/分享
文件名: 李权-Respiratory Research-生信分析文章.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。